TD Cowen Keeps Their Buy Rating on Jasper Therapeutics (JSPR)
Protect Your Portfolio Against Market Uncertainty
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Werber covers the Healthcare sector, focusing on stocks such as Ionis Pharmaceuticals, Argenx Se, and Amgen. According to TipRanks, Werber has an average return of 5.2% and a 46.89% success rate on recommended stocks.
Jasper Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $60.38.
Based on Jasper Therapeutics' latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.17 million and a net profit of $46.95 million. In comparison, last year the company earned a revenue of $2.05 million and had a GAAP net loss of $16.58 million
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
26 minutes ago
- Business Insider
TD Securities Reaffirms Their Buy Rating on Rogers Comm Cl A (RCI.A)
In a report released on July 24, Vince Valentini from TD Securities maintained a Buy rating on Rogers Comm Cl A, with a price target of C$58.00. The company's shares closed last Friday at C$50.15. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Valentini covers the Communication Services sector, focusing on stocks such as Rogers Communication, Rogers Comm Cl A, and Quebecor. According to TipRanks, Valentini has an average return of 0.8% and a 54.80% success rate on recommended stocks. In addition to TD Securities, Rogers Comm Cl A also received a Buy from Desjardins's Jerome Dubreuil in a report issued on July 24. However, on the same day, Scotiabank maintained a Hold rating on Rogers Comm Cl A (TSX: RCI.A). The company has a one-year high of C$59.00 and a one-year low of C$38.01. Currently, Rogers Comm Cl A has an average volume of 2,831.
Business Insider
2 hours ago
- Business Insider
The Week That Was, The Week Ahead: Macro & Markets, July 27, 2025
Everything to Know about Macro and Markets The S&P 500 (SPX) touched new intraday highs on Friday, ending the week up 1.5%. Major indices finished the week on a strong note, thanks to solid corporate earnings and favorable trade developments. The Nasdaq-100 (NDX) and the Dow Jones Industrial Average (DJIA) ended the week 0.9% and 1.3% higher, respectively. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Weekly Gains on Strong Earnings and Trade Deals The S&P 500 posted its fifth straight day of closing records on Friday. Interestingly, the index ended above the 6,300 level for the first time on Monday. Strong earnings reported by several companies, notably by Google parent Alphabet (GOOGL) and telecom giant Verizon (VZ), fueled last week's rally. According to FactSet, out of the 34% of S&P 500 companies that have reported Q2 results so far, 80% have exceeded earnings expectations, a proportion that is above the 5-year average of 78%. However, the magnitude of earnings surprises is below average levels. Additionally, the trade agreement between the U.S. and Japan eased concerns about the ongoing tariff wars and contributed to last week's rally. U.S. President Donald Trump called it 'perhaps the largest Deal ever made,' while adding that Japan would invest $550 billion in the U.S. The deal lowers the tariffs on auto exports, a major driver of Japan's economy, to 15% from the existing 25% that is imposed across countries. A Big Week Ahead The week ahead is expected to be quite eventful, given that it includes the August tariff deadline, the July Federal Open Market Committee (FOMC) meeting, earnings reports from four of the Magnificent 7 stocks, and some key economic releases. The Federal Reserve's two-day policy meeting will be in focus this week, especially due to President Trump's persistent attacks on the central bank's Chair Jerome Powell. The independence of the Fed is being debated, with reporters expected to question Powell about the same at the post-meeting press conference. Despite growing pressure from Trump to slash interest rates, the Fed is expected to hold the benchmark short-term borrowing rate steady in a target range of 4.25% to 4.50%. Meanwhile, the August 1 deadline to raise tariffs is approaching this week. Trump's erratic trade policy decisions have been making headlines. Following the trade agreement with Japan, all eyes are on the possibility of a deal with the European Union (EU). Aside from Trump's trade stance, earnings from four of the Magnificent 7 stocks – Meta Platforms (META), Microsoft (MSFT), Amazon (AMZN), and Apple (AAPL), are eagerly awaited. Investors will be focusing on the commentary from management of these companies regarding the business backdrop and artificial intelligence (AI) spending. Finally, the Personal Consumption Expenditure (PCE) price index report, scheduled for release on Thursday, and the July nonfarm payrolls report, due on Friday, could impact investor sentiment. Experts expect the jobs report to indicate a deceleration in job additions in July compared to the previous month. Meanwhile, the PCE price index is expected to show a rise in inflation. Stocks That Made the News Alphabet impressed investors with its market-beating second-quarter revenue and earnings. The company raised its capital expenditure guidance for 2025 from $75 billion to $85 billion to support robust demand for its cloud offerings amid the ongoing AI boom. Verizon also delivered upbeat results for the June quarter, thanks to strength in its wireless service business. The company raised the lower end of its full-year earnings guidance to reflect strong demand for its premium plans and the Trump administration's new tax law. IBM (IBM) stock fell even after delivering better-than-expected second-quarter results. The company's software business lagged the Street's revenue expectations. The tech giant also noted that some clients are being cautious in signing new deals due to geopolitical pressures. Tesla (TSLA) reported dismal second-quarter results, with the electric vehicle (EV) maker's CEO Elon Musk cautioning investors about a 'few rough quarters' ahead due to the expiration of the federal tax credits. TSLA stock is down 22% year-to-date, as investors are concerned about weak demand due to macro pressures and rising competition, a lack of innovation, and Musk's political ambitions. Intel (INTC) reported mixed results for the second quarter. The chip giant exceeded the consensus revenue expectations, but the bottom line fell short of estimates. Further, CEO Lip-Bu Tan announced significant cuts in chip factory construction. The company is streamlining its operations and cutting costs in an attempt to revive its business. Kohl's (KSS) made headlines this week as it became the latest stock to join the meme stock frenzy. Retail investors are buying stocks of companies like Kohl's and online residential real estate platform Opendoor Technologies (OPEN), which generally have high short seller interest, to trigger rapid rallies. UnitedHealth (UNH) stock declined after the health insurer disclosed in an SEC filing that it 'proactively' reached out to the U.S. Department of Justice (DOJ) after reports of investigations into certain aspects of the company's participation in the Medicare program surfaced. The company added that it has started complying with formal criminal and civil requests from the DOJ. Data analytics company Palantir Technologies (PLTR) stock continued to rally this week, thanks to AI tailwinds. PLTR stock is now one of the 20 most valuable companies in the U.S. Paramount (PARA) secured the Federal Communications Commission's (FCC) approval for the $8 billion merger with Skydance Media. The Q2 2025 earnings season is in full swing, with many prominent U.S. companies' earnings scheduled for this week. Spotlight will be on the earnings reports of PayPal (PYPL), Visa (V), Boeing (BA), SoFi Technologies (SOFI), UnitedHealth (UNH), Microsoft (MSFT), Meta Platforms (META), Alibaba (BABA), Ford (F), Apple (AAPL), Amazon (AMZN), Exxon Mobil (XOM), and Chevron (CVX).
Business Insider
5 hours ago
- Business Insider
UnitedHealth (UNH) Is About to Report Q2 Earnings on July 29. Here Is What to Expect
UnitedHealth (UNH), one of the prominent players in the health insurance space, is scheduled to announce its second-quarter earnings on July 29. The stock has dropped 43.8% year-to-date, hit by several issues, including the suspension of its guidance, escalating medical costs, and a leadership shakeup that included the sudden departure of its CEO, Andrew Witty. Wall Street analysts expect the company to report earnings per share of $4.48, representing a 34% decrease year-over-year. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Meanwhile, revenues are expected to increase by 13% from the year-ago quarter to $111.5 billion, according to data from the TipRanks Forecast page. It's important to note that UNH has an impressive track record with earnings, having exceeded EPS estimates in eight out of the past nine consecutive quarters. On July 24, UnitedHealth Group (UNH) revealed in an SEC filing that it is under formal investigation by the Department of Justice (DOJ) over its Medicare billing practices. The company said it is cooperating with both civil and criminal probes into whether it improperly raised patient diagnoses to secure higher payments from the government. J.P. Morgan analyst Lisa Gill remains optimistic ahead of UnitedHealth's earnings, viewing the DOJ probe as part of a broader industry trend. She maintained an Overweight rating on the stock, expecting a potential rebound despite near-term uncertainty. Analyst's Views Ahead of UNH's Q2 Earnings Heading into the Q2 print, Deutsche Bank analyst George Hill lowered his price target to $328 from $362 but reiterated a Buy rating. The analyst noted that investor sentiment 'has deteriorated significantly' due to a series of unfavorable news. The top-rated analyst lowered his estimates, citing ongoing concerns around Optum Health, the company's healthcare services unit. Also, Leerink Partners analyst Whit Mayo lowered the price target for UNH stock to $340 from $355 and reiterated a Buy rating. He remains 'cautiously optimistic' about the stock heading into Q2 earnings, given the challenging backdrop. Options Traders Anticipate a Large Move Using TipRanks' Options tool, we can see what options traders are expecting from the stock immediately after its earnings report. The expected earnings move is determined by calculating the at-the-money straddle of the options closest to expiration after the earnings announcement. If this sounds complicated, don't worry; the Options tool does this for you. Indeed, it currently says that move in either direction. Is UNH a Good Buy Now? Turning to Wall Street, UNH stock has a Moderate Buy consensus rating based on 18 Buys, five Holds, and one Sell assigned in the last three months. At $348.12, the average UnitedHealth stock price target implies a 23.86% upside potential.
